These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4317815)

  • 1. [Toward phosphate therapy of bladder stones].
    Hallwachs O; Vogelsang G; Röhl L
    Z Urol Nephrol; 1969 Jan; 62(1):29-35. PubMed ID: 4317815
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of phosphate therapy of urinary calculi].
    Kollwitz AA; Kracht H; Meier F
    Urologe; 1966 Jul; 5(4):168-71. PubMed ID: 4296919
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of bladder stone disease in Thailand. X. Effect of orthophosphate and nonfat dry milk supplementations on urine composition.
    Valyasevi A; Dhanamitta S; Van Reen R
    Am J Clin Nutr; 1969 Feb; 22(2):218-27. PubMed ID: 4304084
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of bladder stone disease in Thailand. XVII. Effect of exogenous source of oxalate on crystalluria.
    Valyasevi A; Dhanamitta S
    Am J Clin Nutr; 1974 Aug; 27(8):877-82. PubMed ID: 4846411
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxalate metabolism. 3.
    Hagler L; Herman RH
    Am J Clin Nutr; 1973 Sep; 26(9):1006-10. PubMed ID: 4580435
    [No Abstract]   [Full Text] [Related]  

  • 6. Kidney and bladder stones in India.
    Teotia M; Teotia SP
    Postgrad Med J; 1977; 53 Suppl 2():41-51. PubMed ID: 882476
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of urinary calculi by chemical methods.
    Naqvi SA; Rizvi SA; Shahjehan S
    J Pak Med Assoc; 1984 Jun; 34(6):147-53. PubMed ID: 6433055
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary tract stones in childhood.
    Watts HG
    N Z Med J; 1974 Dec; 80(530):533-7. PubMed ID: 4532206
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative infrared spectrophotometric and pathologic-anatomical studies in urolithiasis].
    Arnold W; Seemann N
    Dtsch Med Wochenschr; 1968 Sep; 93(38):1791-5. PubMed ID: 5673250
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on bladder stone disease in Egyptian children. VI. Crystalluria in the stone patients.
    Loutfi A; Van Reen R; Abdel-Hamid G
    J Egypt Med Assoc; 1974; 57(3-4):137-45. PubMed ID: 4430772
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pyrophosphate levels of the urine in lithiasis].
    Sommer-Tsilenis E; Kallistratos G; Timmermann A
    Munch Med Wochenschr; 1967 Feb; 109(6):293-5. PubMed ID: 4298874
    [No Abstract]   [Full Text] [Related]  

  • 12. [Review. Physiopathology and treatment of urolothiasis].
    Fleisch H; Bisaz S
    Z Urol Nephrol; 1966 Nov; 59(11):785-800. PubMed ID: 4298145
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of bladder stone disease in Thailand. XI. Effect of 4-hydroxy-L-proline and orthophosphate supplementations on crystalluria.
    Dhanamitta S; Valyasevi A; Van Reen R
    Am J Clin Nutr; 1970 Mar; 23(3):371-6. PubMed ID: 5436643
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary stones in Western Algeria: study of the composition of 1,354 urinary stones in relation to their anatomical site and the age and gender of the patients].
    Djelloul Z; Djelloul A; Bedjaoui A; Kaid-Omar Z; Attar A; Daudon M; Addou A
    Prog Urol; 2006 Jun; 16(3):328-35. PubMed ID: 16821346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on bladder stone disease in Thailand. XV. Factors affecting the solubility of calcium oxalate.
    Chulkaratana S; Van Reen R; Valyasevi A
    Invest Urol; 1971 Nov; 9(3):246-50. PubMed ID: 5137334
    [No Abstract]   [Full Text] [Related]  

  • 16. [Administration of a diphosphonate in urinary calculi prevention].
    Baumann JM; Ganz U; Bisaz S; Fleisch H; Rutishauser G
    Helv Chir Acta; 1974 Sep; 41(4):421-4. PubMed ID: 4369478
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcium nephrolithiasis and phosphate therapy. Long term study (65 cases) (author's transl)].
    Lagrue G; Hioco D; Kazandjian M; Cattaneo A; Cassagnol M
    Sem Hop; 1980 Jun 8-15; 56(21-24):1043-8. PubMed ID: 6248982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the development of experimentally induced urinary stones in rats.
    Fraser D; Russell RG; Pohler O; Robertson WG; Fleisch H
    Clin Sci; 1972 Feb; 42(2):197-207. PubMed ID: 5058574
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary bladder stone disease in children--crystallisation studies with special reference to urinary excretion of pyrophosphates.
    Teotia SP; Teotia M; Teotia NP
    Indian J Pediatr; 1974 Sep; 41(320):293-8. PubMed ID: 4374434
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the significance of the renal excretion of pyrophosphate].
    Gundlach G; Hoppe-Seyler GF; Dörr H; Bressel M
    Urologe; 1968; 7(1):56-61. PubMed ID: 4297581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.